HLB Therapeutics Co.,Ltd.
115450
Rang în acțiuni
#18192
HLB Therapeutics Co.,Ltd. operates as a biotechnology company, focusing on the... HLB Therapeutics Co.,Ltd. operates as a biotechnology company, focusing on the creation of pharmaceutical products for both the South Korean and international markets. A significant part of its research and development initiatives includes GBT-201, a compound utilizing Thymosin beta designed to treat various eye ailments such as dry eye syndrome and neurotrophic keratopathy. Additionally, the company is advancing OKN-007 as a potential therapy for glioblastoma brain tumors. Beyond its pharmaceutical endeavors, HLB Therapeutics is also involved in the wholesale distribution of vaccines and the production of electrical and electronic components like motors, pumps, and transformers. The company, which established its roots in 2000 and is based in Seongnam, South Korea, underwent a name change in December 2021, transitioning from its former identity as G-treeBNT Co., Ltd. to its current designation.
Preț acțiune
$2.05
Capitalizare de piață
$193.14M
Schimbare (1 zi)
9.36%
Schimbare (1 an)
0.13%
Țară
KR
Tranzacționează HLB Therapeutics Co.,Ltd. (115450)
Categorie
Healthcare
Istoricul spliturilor pentru HLB Therapeutics Co.,Ltd. (115450)
Acțiunea HLB Therapeutics Co.,Ltd. (simbol: 115450) a trecut printr-un total de 0 splituri.
Cel mai recent split a avut loc pe Oct 22, 2026.
O acțiune 115450 cumpărată înainte de Oct 22, 2026 este echivalentă astăzi cu 0 acțiuni 115450.
Cel mai recent split a avut loc pe Oct 22, 2026.
O acțiune 115450 cumpărată înainte de Oct 22, 2026 este echivalentă astăzi cu 0 acțiuni 115450.
Listă splituri acțiuni
| An | Split | Multiplu | Multiplu cumulativ |
|---|---|---|---|
| Nu sunt suficiente date pentru perioada selectată. | |||
Splituri pentru companii similare sau competitori
| Companie | Număr total de splituri | Multiplu cumulativ | Țara |
|---|---|---|---|
| 1 | x2 |
US
|
|
| 0 | - |
US
|
|
| 1 | x3 |
AU
|
|
| 0 | - |
NL
|
|
| 0 | - |
CH
|
